Puhan He, DMD, MD
Dr. He earned her DMD from Harvard School of Dental Medicine in 2019 and her MD from the University of Pennsylvania in 2022. She completed her Oral and Maxillofacial Surgery residency at Penn and is now an Assistant Professor in Penn’s Department of Oral and Maxillofacial Surgery. Her research focuses on cell-free regenerative medicine, particularly the use of extracellular vesicles and biomaterial-based approaches to promote tissue repair and regeneration. Her work has earned the Osteo Science Foundation Resident Research Award and AAOMS Oral Presentation Award. She recently was an invited speaker in the 11th International Conference in Vietnam on the Development of Biomedical Engineering for her work. She has published extensively and contributed to surgical textbooks.
Disclosure: Dr. He has no relevant financial relationships to disclose.
James Melville, DDS
Dr. James C. Melville DDS FACS is a Tenured Professor at the University of Texas Health Science Center at Houston UTHealth, specializing in Oral, Head & Neck Oncology, and Microvascular Reconstructive Surgery. Recognized for Dr. Melville’s outstanding contributions, he has received prestigious awards such as the Faculty Educator Development Award, AAOMS Advocacy Challenge Coin and the AAOMS Clinical Research Award.With extensive experience as a diplomat and examiner, he is a fellow of several prominent surgical associations and has authored numerous textbook chapters and peer-reviewed articles. Dr. Melville’s expertise and dedication continue to shape the field of oral and maxillofacial surgery.
Disclosure: Dr. Melville serves as a Key Opinion Leader for AxoGen, Inc., ACell, Inc./Integra, Kerecis, and MTF, and has received honoraria from AxoGen, Inc., ACell, Inc./Integra, and MTF. Dr. Melville also serves on the Scientific Advisory Board of Proteocyte AI, with no financial compensation, and as Educational Faculty for the Strasbourg Osteosynthesis Group (S.O.R.G.), for which he receives honoraria.